article thumbnail

Marquis Who’s Who Honors David R. Elmaleh, PhD, with Inclusion in Who’s Who in the World

The Pharma Data

Elmaleh’s research has yielded compounds with potential in oncology, heart disease and neurodegenerative conditions, BOSTON, MA, October 23, 2020 /24-7PressRelease/ — Marquis Who’s Who, the world’s premier publisher of biographical profiles, is proud to honor David.

article thumbnail

Marquis Who’s Who Honors James D. McChesney, PhD, with Inclusion in Who’s Who in the World

The Pharma Data

Inspired by a lifelong passion for nature and a fascination with the potential to address disease using naturally derived compounds, he earned a Bachelor of Science in chemical technology at Iowa State University of Science and Technology in 1961.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Women in Stem with Dr Emily Leproust

Drug Target Review

I started my journey in chemistry – first as an undergraduate and then in my PhD programme at the University of Houston, where I focused on organic chemistry and nucleic acids chemistry. I originally wanted to be a doctor but that’s a second-tier track in France. I’m a CEO with a background in chemistry.

DNA 115
article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

She is currently a Senior drug discovery scientist working across Cell Engineering, Cell Biology and Functional Genomics teams, using CRISPR/Cas9 and Next Generation Sequencing for target identification, target validation and drug development in the oncology disease area.

article thumbnail

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

Jens Fischer, PhD, Program Manager, Large Molecule Research Therapeutic Modalities, Roche Pharma Research and Early Development (pRED), on: ‘ Bispecific and next-generation antibodies for non-oncology indications such as ophthalmologic and neurologic diseases’.